Biochemistry, Genetics and Molecular Biology
Adenoviridae
41%
Adenovirus Vector
16%
Ataxia Telangiectasia Mutated
6%
BRCA1
28%
Cancer Cell
94%
Cell Cycle
24%
Cell Cycle Arrest
18%
Cell Growth
6%
Chloramphenicol Acetyltransferase
8%
Cisplatin
10%
Cross Resistance
9%
Cytotoxicity
12%
Dihydrofolate Reductase
21%
DNA Damage
15%
DNA Flanking Region
11%
DNA Topoisomerase
6%
Enzyme
10%
Estrogen Receptor
17%
Exon
6%
Expression Vector
8%
Extracellular Signal-Regulated Kinases
8%
Gene Expression
14%
Gene Therapy
13%
Glutathione Peroxidase
10%
Glutathione S-Transferase
34%
GTPase
8%
Hematopoietic Stem Cell
6%
Kinase
19%
Messenger RNA
21%
Methotrexate
13%
Minigene
12%
Mouse
10%
Multidrug Resistance
26%
Normal Human
8%
Nucleotide Sequence
11%
P-Glycoprotein
9%
P14arf
8%
P16
8%
P53
54%
Phosphotransferase
19%
Promoter Region
24%
Protein Kinases
9%
Protein P53
13%
RAC1
8%
Topoisomerase
6%
Transcription
21%
Transfection
7%
Transgene
6%
Tumor Progression
6%
Wild Type
48%
Pharmacology, Toxicology and Pharmaceutical Science
Adenoviridae
27%
Adenovirus Vector
9%
Breast Cancer
100%
Camptothecin
8%
Cancer Mortality
6%
Carcinogen
6%
Chemotherapy
25%
Cisplatin
21%
Complementary DNA
14%
Cross-Resistance
9%
Cyclophosphamide
25%
Cytotoxicity
5%
Dihydrofolate Reductase
9%
Doxorubicin
40%
Drug Resistance
7%
Escherichia coli
8%
Estrogen Receptor
11%
Etoposide
9%
Fluorouracil
13%
Folinic Acid
9%
Glutathione
26%
Glutathione Transferase
10%
Granulocyte Colony Stimulating Factor
22%
Granulocyte Macrophage Colony Stimulating Factor
8%
Infection
9%
Liver Nodule
10%
Malignant Neoplasm
15%
Metastatic Breast Cancer
31%
Methotrexate
19%
Mitoxantrone
6%
Mouse
7%
Multidrug Resistance Associated Protein
9%
Multiple Drug Resistance
20%
Neoplasm
35%
Normal Human
8%
Overall Survival
6%
Oxanthrazole
8%
P-Glycoprotein
11%
Paclitaxel
34%
Pancreas Cancer
8%
Pharmacokinetics
10%
Protein P53
34%
Recurrent Disease
11%
Reduced Folate Carrier
9%
Renal Cell Carcinoma
5%
Tamoxifen
14%
Transferase
27%
Tumor Suppressor Protein
12%
Verapamil
8%
Xenobiotic Agent
5%
Keyphrases
5-Azacytosine
6%
5-fluorouracil (5-FU)
8%
Adenoviral Vector
5%
Adenovirus
10%
Advanced Breast Cancer
8%
Apoptosis
5%
Breast Cancer
16%
Breast Cancer Cells
9%
Breast Cancer Risk
9%
Breast Cancer Risk Reduction
12%
Breast Cancer Susceptibility Gene 1 (BRCA1)
17%
Cancer Cells
7%
Cell Cycle Arrest
14%
Chemotherapy
10%
CHK1 Kinase
5%
Cip1
6%
Clinical Practice Guidelines
8%
Complementary DNA (cDNA)
7%
Cyclophosphamide
5%
DNA Damage
14%
Doxorubicin
16%
Doxorubicin-cyclophosphamide
8%
Glutathione S-transferase
13%
Glutathione S-transferase Genes
8%
Glycoprotein Gene
5%
Granulocyte Colony-stimulating Factor (G-CSF)
18%
Human Breast Cancer Cells
17%
Human Tumors
8%
Induced Apoptosis
7%
Irradiation
8%
Leucovorin
8%
MCF-7
16%
MCF-7 Cells
13%
MDA-MB-231
6%
Metastatic Breast Cancer
12%
Methotrexate
12%
Methylenetetrahydrofolate Reductase (MTHFR)
7%
Multidrug Resistance
11%
Multidrug Resistance Protein 1 (MDR1)
17%
Oncology
8%
Overexpression
11%
P-glycoprotein (P-gp)
12%
P27Kip1
8%
Phase I Study
12%
Recombinant Adenovirus
19%
Reinitiation
8%
Taxol
8%
Therapy Approaches
5%
U2OS
7%
Wild-type p53
12%